In the News July 7, 2022

The Pink Sheet | Could Pharmacist Prescribing Grow in Wake of Paxlovid Experience?

Marc Scheineson comments on what the Food and Drug Administration’s emergency use authorization update for COVID-19 drug Paxlovid could mean for other therapies.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.